Health Care Service Corporation’s 2025 annual report is trying very hard to tell a growth story, but the financials tell a different one.
HCSC revenue grew to $66.8 billion, fueled in part by the acquisition of The Cigna Group’s Medicare Advantage and CareAllies businesses, and membership climbed to more than 27 million people. On paper, this should have looked like a year of momentum. Instead, one of the country’s largest Blues plans looks like it lost control of the math.
HSCS posted a $1.917 billion net loss and a staggering $3.476 billion underwriting loss after medical costs surged to $63.1 billion in 2025. The underwriting losses are where the real story sits. Health plans can survive administrative inefficiency, and they can survive integration friction. What they can’t survive indefinitely is medical cost trend outrunning premium growth at this scale.
The HCSC 2025 annual report says “growth”
HCSC repeatedly frames the year around expansion, investment, and long-term positioning. The company highlights:
- Record membership growth
- Expanded national reach
- Increased provider engagement
- Investments in value-based care
- Expanded behavioral health offerings
- Technology modernization
- Improved access to care
The report attributes performance to “record membership and revenue growth related to our acquisition” and “continuing headwinds consistent across the managed care industry.”
Growth is the headline HCSC wants readers focused on. The losses are contextualized as part of a broader industry environment rather than the result of any specific operational or strategic problem.
The HCSC 2025 annual report never says “utilization”
Benefit expenses increased by roughly $6 billion year-over-year. You don’t see that kind of increase through routine trend movement or administrative cost inflation. That’s what happens when people use materially more care, patients arrive sicker, and the cost per episode keeps climbing. And yet the report never directly discusses a utilization spike.
It also never isolates the performance of the acquired Medicare Advantage population from Cigna. HCSC confirms the acquisition drove membership and revenue growth, but never addresses whether those members are profitable, whether they carry higher-than-expected acuity, or whether the acquisition materially worsened medical cost performance.
The omissions leave the central question unanswered: did HCSC grow into a problem it could no longer manage?
The underwriting loss is the real warning sign
The phrase “prudent financial management” appears in the same report as a $3.476 billion underwriting loss.
Revenue and membership increased materially in 2025, but medical costs increased much faster than the pricing structure could absorb.
Health plans price products months before they fully understand how utilization, acuity, reimbursement pressure, and treatment patterns are going to evolve. When those assumptions move too far in the wrong direction, margins deteriorate quickly. Adding a large Medicare Advantage acquisition into an already volatile utilization environment only increases the difficulty of controlling costs in real time.
The issue is probably not as simple as HCSC buying a “bad” book of business from Cigna. A more likely explanation is that the company added significant operational and actuarial complexity at the same moment the broader managed care environment became more expensive and less predictable.
The financials suggest the organization grew faster than it could stabilize the underlying cost structure. Revenue and membership growth remained strong throughout the year. The underwriting results show how difficult it became to manage the medical expense attached to that growth.
What happens next
Losses of this size don’t stay isolated inside a balance sheet.
Providers should expect tougher contract negotiations, increased utilization management pressure, more aggressive denial activity, tighter reimbursement structures, and heavier emphasis on value-based arrangements.
Patients will feel it differently. Higher out-of-pocket exposure, more confusion around approvals and coverage, and growing hesitation around what care will ultimately cost all tend to follow periods like this.
Much of the HCSC 2025 annual report focuses on access, innovation, and value. The financials point toward a more difficult operating environment underneath those themes. Managing medical cost trend is becoming significantly harder, even for large organizations with enormous scale, established provider networks, and sophisticated care management infrastructure.
That is the larger takeaway from this report. HCSC continued to grow. The challenge was controlling the cost structure attached to that growth.
